Xeris Biopharma Holdings (XERS) Change in Inventory (2020 - 2026)
Xeris Biopharma Holdings' (XERS) quarterly Change in Inventory came in at -$851000.0 in Q1 2026, down 123.53% YoY from $3.6 million in Q1 2025, and down 121.22% on a QoQ basis from $4.0 million in Q4 2025.
Xeris Biopharma Holdings (XERS) Change in Inventory (2020 - 2026) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 7 years of Change in Inventory data on file, last reported at -$851000.0 in Q1 2026.
- Quarterly Change in Inventory fell 123.53% year-over-year to -$851000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.8 million (up 47.19% YoY) and the FY2025 annual result came in at $19.3 million, up 119.61% from the prior year.
- Change in Inventory retreated to -$851000.0 in Q1 2026, from $4.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $7.6 million in Q2 2025 to a low of -$851000.0 in Q1 2026.
- A 5-year average of $2.9 million and a median of $2.3 million in 2024 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2023 — Change in Inventory jumped 4922.3% — and 2026, when it sank 123.53%.
- Tracing XERS's Change in Inventory over 5 years: stood at $5.5 million in 2022, then tumbled by 74.55% to $1.4 million in 2023, then surged by 123.91% to $3.1 million in 2024, then grew by 27.86% to $4.0 million in 2025, then tumbled by 121.22% to -$851000.0 in 2026.
- The last three Change in Inventory figures came in at -$851000.0 (Q1 2026), $4.0 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Xeris Biopharma Holdings | 1.51 Bn | 1.39 Bn | 79.59 Mn | 9.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.50 Mn |
| Jun 30, 2026 | 9.50 Mn |
| Mar 31, 2026 | -851,000.00 |
| Mar 31, 2026 | -851,000.00 |
| Dec 31, 2025 | 4.01 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | 7.57 Mn |
| Jun 30, 2025 | 7.57 Mn |
| Mar 31, 2025 | 3.62 Mn |
| Mar 31, 2025 | 3.62 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 2.27 Mn |
| Jun 30, 2024 | 2.27 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Mar 31, 2024 | 2.33 Mn |